XBiotech (XBIT) Return on Sales [ROS] (2020 - 2023)
XBiotech (XBIT) reported Return on Sales [ROS] of -2207.44% for Q3 2023, down 1827.14 percentage points from -380.30% a year earlier and down 1118.53 percentage points from the prior quarter.
Powered by 
Analysis
XBiotech (XBIT) Return on Sales [ROS] (2020 - 2023) Analysis & Trends
For FY2022, XBiotech posted Return on Sales [ROS] of -860.10%, down 723.74 percentage points from FY2021.
- By year, Return on Sales [ROS] came in at -136.36% in FY2021 (-94.82 pp) and -41.54% in FY2020.
- The Q3 2023 figure ranks as the lowest quarterly Return on Sales [ROS] in data going back to Q1 2020.
- Year over year, Return on Sales [ROS] gained in 1 of the last seven quarters, with an average year-over-year change of -554.77 percentage points.
- The high point for year-over-year Return on Sales [ROS] in five years was Q1 2023 (a gain of 658.22 percentage points); the low point was Q3 2023 (a drop of 1827.14 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 52.42% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 30.89% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 32.98% |
| 10 | XBiotech | 58.23 Mn | -439.75 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | -2,207.44% |
| Jun 30, 2023 | -1,088.91% |
| Mar 31, 2023 | -910.78% |
| Sep 30, 2022 | -380.30% |
| Jun 30, 2022 | -790.46% |
| Mar 31, 2022 | -1,569.00% |
| Dec 31, 2021 | -159.84% |
| Sep 30, 2021 | -82.56% |
| Jun 30, 2021 | -234.36% |
| Mar 31, 2021 | -73.26% |
| Dec 31, 2020 | -93.41% |
| Sep 30, 2020 | -44.27% |
| Jun 30, 2020 | -42.03% |
| Mar 31, 2020 | -17.12% |
API Access
XBiotech Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();